|
|
|
|
|
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
愈酚伪麻氢可酮口服溶液治疗咳嗽等症状的有效性和安全性的随机对照临床研究
[Translation] A randomized controlled clinical study on the efficacy and safety of fenugreek pseudomathenad hydrocodone oral solution in the treatment of cough and other symptoms
以愈酚伪麻待因口服溶液为对照,评价愈酚伪麻氢可酮口服溶液治疗由普通感冒和流行性感冒引起的咳嗽且伴有鼻塞、多痰、流涕、喷嚏等症状的有效性和安全性
[Translation] To evaluate the efficacy of the oral solution of Yufenpine and Pseudine Hydrocodone in the treatment of cough caused by common cold and influenza accompanied by nasal congestion, phlegm, runny nose, sneezing and other symptoms compared with the oral solution of Yufenpine and Pseudine and security
[Translation] Pharmacokinetics study of oral solution of yuphenol-pseudo-hydrocodone in humans
进行本品的药代试验,测定主要成分经时血药和尿药浓度,估算其主要药代参数,了解本品在健康人体内的ADME规律,与愈酚伪麻口服溶液进行药代对比试验,为制定本品II期临床试验方案提供依据,为临床用药的给药剂量依据。
[Translation] Carry out the pharmacokinetic test of this product, measure the concentration of the main components in blood and urine over time, estimate its main pharmacokinetic parameters, understand the ADME law of this product in healthy people, and conduct a pharmacokinetic comparison test with the oral solution of fenugreek , to provide the basis for the formulation of the Phase II clinical trial plan of this product and the basis for the dosage of clinical medication.
采用无对照开放、单剂量顺序给药的研究方法评价复方盐酸替利定口服溶液的药代动力学特性
[Translation] Evaluation of the pharmacokinetic properties of compound tilidine hydrochloride oral solution by an uncontrolled open-label, single-dose sequential administration method
本试验的目的是评价四川抗菌素工业研究所有限公司和国药集团工业有限公司廊坊分公司共同研制的复方盐酸替利定口服溶液人体药代动力学特性及安全性,为临床安全、合理用药提供参考依据。
[Translation] The purpose of this test is to evaluate the human pharmacokinetic properties and safety of compound tilidine hydrochloride oral solution jointly developed by Sichuan Antibiotics Industry Research Institute Co., Ltd. in accordance with.
100 Clinical Results associated with Sichuan Antibiotic Industry Research Institute Co Ltd
0 Patents (Medical) associated with Sichuan Antibiotic Industry Research Institute Co Ltd
100 Deals associated with Sichuan Antibiotic Industry Research Institute Co Ltd
100 Translational Medicine associated with Sichuan Antibiotic Industry Research Institute Co Ltd